-
1 Comment
AdaptHealth Corp is currently in a long term downtrend where the price is trading 13.9% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.9.
AdaptHealth Corp's total revenue sank by 34.2% to $348M since the same quarter in the previous year.
Its net income has dropped by 339.1% to $-66M since the same quarter in the previous year.
Finally, its free cash flow fell by 18.2% to $33M since the same quarter in the previous year.
Based on the above factors, AdaptHealth Corp gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
| ISIN | US00653Q1022 |
| Exchange | NASDAQ |
| CurrencyCode | USD |
| Beta | 1.72 |
|---|---|
| Market Cap | 2B |
| PE Ratio | None |
| Target Price | 12.875 |
| Dividend Yield | None |
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AHCO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026